1MG Pharma Inc., Osaka 567-0085, Japan
Journal of Food and Nutrition Research.
2025,
Vol. 13 No. 8, 301-306
DOI: 10.12691/jfnr-13-8-4
Copyright © 2025 Science and Education PublishingCite this paper: Keiichi Ishido, Yuka Sasakawa, Michiyo Abe, Fumiko Nakaoka, Mayumi Nakao, Kaori Yamamoto, Chizuko Fukuhama, Yasuo Sumida. Identification of Glyasperin B as a Lipolytic Agent with Anti-Obesity Activity from the Licorice Extract of
Glycyrrhiza uralensis.
Journal of Food and Nutrition Research. 2025; 13(8):301-306. doi: 10.12691/jfnr-13-8-4.
Correspondence to: Keiichi Ishido, MG Pharma Inc., Osaka 567-0085, Japan. Email:
k-ishido@mgpharma.co.jpAbstract
Obesity is recognized as a significant public health concern. Although licorice extract from the root of Glycyrrhiza uralensis exhibits anti-obesity effects, limited knowledge regarding its active components has hindered the development of standardized preparations. Therefore, this study aimed to identify the compound responsible for the anti-obesity activity of licorice extract. By isolating and characterizing a compound exhibiting lipolytic activity against 3T3-L1 adipocytes, glyasperin B was identified. In a diet-induced obesity mouse model, the efficacy of licorice extracts correlated with glyasperin B content, suggesting that glyasperin B is a key contributor to the anti-obesity effects of Glycyrrhiza uralensis. This study’s findings may facilitate the standardized preparation of licorice extracts for weight management, potentially aiding in the fight against obesity.
Keywords